The decision follows repeated efforts by Swiss drugmaker Covis Pharma to keep Makena on the U.S. market while it conducted additional studies. The medication was the only drug approved in the U.S. to help reduce the risk of early births in women with a history of preterm deliveries.period of several months so that women taking the drug could complete their treatment.
The decision by FDA Commissioner Robert Califf and the agency’s chief scientist marks the first time the FDA has formally forced the removal of a drug that it initially approved based on promising early data. In all prior cases, drugmakers voluntarily pulled medications after the FDA made clear it intended to order removal.
“It is tragic that the scientific research and medical communities have not yet found a treatment shown to be effective in preventing preterm birth and improving neonatal outcomes,” Califf said in a statement Thursday.
US_FDA will approve this dangerous drug for 12 years while safe and effective NurOwn for 100% fatal disease ALS is blocked by FDACBER. PALS DiedWaiting DyingWaiting MakesNoSense katiecouric USNewsHealth WSJhealth SenSusanCollins POTUS SenatorBraun lisamurkowski
Now do the covid vax
Classic FDA. Bought and paid for by Big Pharma since 1992.
Switzerland Neuesten Nachrichten, Switzerland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Herkunft: WOKVNews - 🏆 247. / 63 Weiterlesen »
Herkunft: ksatnews - 🏆 442. / 53 Weiterlesen »
Herkunft: WashTimes - 🏆 235. / 63 Weiterlesen »
Herkunft: MarketWatch - 🏆 3. / 97 Weiterlesen »